NADENO NANOSCIENCE AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: AF
Annbjørg Eide Falck1976
Chairman of the board: OJ
Ole Jesper Dahlberg1971
Years since formation: 2 years; since Aug 4, 2022
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 10,559,576; 1 share class
Total number of shareholders: 24; 23 companies, 1 person

Financials

Total operating income 2023: 3,415,827; NOK
Annual total result 2023: -9,974,491; NOK
Total equity 2023: 31,229,000; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
AF Annbjørg Eide Falck 1976	Managing Director/CEO	9.09 % indirectly

Board

Name	Role	Shares
OJ Ole Jesper Dahlberg 1971	Chairman	-
EA Eli Grong Aursand 1981	Board Member	-
JH Jonas Hallén 1978	Board Member	-
JT Jan Trygve Håbrekke 1963	Board Member	8.44 % indirectly
CJ Cristianne Johanna Ferdinand Rijcken 1979	Board Member	-

Others

Name	Role	Shares
D DELOITTE AS	Auditor	-
S SPAREBANK 1 REGNSKAPSHUSET SMN AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
YA Yrr Asbjörg Mørch 1975	-	9.47 % indirectly
AF Annbjørg Eide Falck 1976	Managing Director/CEO	9.09 % indirectly
JT Jan Trygve Håbrekke 1963	Board Member	8.44 % indirectly
AØ Asgeir Østvik 1963	-	6.17 % indirectly
AT Alf Tony Tokle 1971	-	1.69 % indirectly
JT Jannicke Tokle 1973	-	1.69 % indirectly
CF Carl Fredrik Eide 1975	-	1.63 % indirectly
BC Bjørn Christian Eide 1973	-	1.63 % indirectly
PJ Per Jørgen Weisethaunet 1971	-	1.52 % indirectly
HF Harald Fredrik Hodne Ulltveit-Moe 1972	-	1.52 % indirectly

Last update: Jul 3, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
S SINTEF VENTURE V AS	Ordinary shares	3,117,857	29.53 %
Y YRR HOLDING AS	Ordinary shares	1,000,000	9.47 %
F FALCKA HOLDING AS	Ordinary shares	960,000	9.09 %
I INVESTITUDE AS	Ordinary shares	891,429	8.44 %
S SONDO FUND 1 AS	Ordinary shares	725,404	6.87 %
Y YSTVIKA HOLDING AS	Ordinary shares	651,429	6.17 %
D DEVICO HOLDING AS	Ordinary shares	571,429	5.41 %
E ESMAR AS	Ordinary shares	382,857	3.63 %
C CALYPSO INVEST AS	Ordinary shares	320,000	3.03 %
F FARVATN VENTURE AS	Ordinary shares	302,857	2.87 %
H HELIFT AS	Ordinary shares	242,143	2.29 %
N NADENO NANOSCIENCE AS	Ordinary shares	230,000	2.18 %
H HARMONIUM INVEST AS	Ordinary shares	160,000	1.52 %
P PETORS AS	Ordinary shares	160,000	1.52 %
A ANGEN EIENDOM AS	Ordinary shares	160,000	1.52 %
3 3C UTVIKLING AS	Ordinary shares	142,857	1.35 %
E EIDCO AS	Ordinary shares	142,857	1.35 %
T TURTLE INVEST AS	Ordinary shares	122,857	1.16 %
E ELAR HOLDING AS	Ordinary shares	81,600	0.77 %
TL Torkil Leinum 1964	Ordinary shares	50,000	0.47 %
T TORSEN TANKERS & TOWERS AS	Ordinary shares	48,000	0.45 %
O OSKAR INVESTMENT AS	Ordinary shares	48,000	0.45 %
D DRM INVEST AS	Ordinary shares	32,000	0.3 %
H HERING AS	Ordinary shares	16,000	0.15 %

Shares owned by the NADENO NANOSCIENCE AS

Name	Share class	Number of shares	Share
N NADENO NANOSCIENCE AS	Ordinary shares	230,000	2.18 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022
Total operating income	3,415,827	600,000
Annual Total Result	-9,974,491	-2,857,081
Total assets	35,500,132	17,680,588
Total liabilities	4,271,132	1,471,239
Total equity	31,229,000	16,209,349

P&L

Year	2023	2022
Total operating income	3,415,827	600,000
Total operating costs	13,563,855	3,425,042
Operating result	-10,148,028	-2,825,042
Financial income/costs	173,538	-32,040
Profit before tax	-9,974,491	-2,857,081
Total tax & extraordinary income/cost	0	0
Annual Total Result	-9,974,491	-2,857,081

Balance overview

Year	2023	2022
Total fixed assets	81,301	130,905
Total current assets	35,418,831	17,549,682
Total assets	35,500,132	17,680,588
Short term debt	4,271,132	1,471,239
Long term debt	0	0
Total liabilities	4,271,132	1,471,239
Contributed capital	31,229,000	19,066,430
Retained earnings	0	-2,857,081
Total equity	31,229,000	16,209,349
Total equity and liabilities	35,500,132	17,680,588

NADENO NANOSCIENCE AS929 594 622